Early research (Phase 1)Study completedNCT05233826
What this trial is testing
Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19
Who this might be right for
COVID-19SARS-CoV-2
Codagenix, Inc 20
Showing 17 of 0 results